Serbian Court Upholds Krka's Appeal on Zyllt Sales Ban
Novo Mesto, 12 December - Pharma company Krka has scored a victory in its ongoing legal battle with French company Sanofi Aventis in Serbia, as a higher court overturned a ban on sales of its anticoagulant Zyllt imposed in November by a court of first instance.
The rest of this news item is available to subscribers.
The news item consists of 663 characters (without spaces) or 133 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.